CHA Vaccine Research Institute — Investor Relations & Filings
CHA Vaccine Research Institute is a research-oriented biotechnology company focused on developing vaccines and immunotherapeutics for the prevention and treatment of infectious diseases. The company's core strategy involves leveraging proprietary adjuvant platforms, such as L-pampo and L-pampo, which are based on Toll-like receptor (TLR) ligands, to enhance vaccine efficacy. Its development pipeline includes a third-generation prophylactic vaccine and a therapeutic vaccine for Hepatitis B (HBV), a recombinant vaccine for herpes zoster (shingles), and an improved influenza vaccine. In addition to its vaccine portfolio, the institute is developing immunotherapeutic proteins like recombinant Mannose-Binding Lectin (MBL) for broad-spectrum pathogen suppression.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 주주명부폐쇄기간또는기준일설정 | 2025-12-16 | Korean | |
| 기업설명회(IR)개최 | 2025-10-28 | Korean | |
| 투자판단관련주요경영사항(임상시험계획승인신청) (재조합 대상포진 백신(CVI-VZV-001)의 제 2상 임상시험 계획 승인 신청(IND)) | 2025-10-15 | Korean | |
| 기업설명회(IR)개최 | 2025-10-15 | Korean | |
| 주식등의대량보유상황보고서(일반) | 2025-09-30 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2025-09-25 | Korean |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 10214101 | 주주명부폐쇄기간또는기준일설정 | 2025-12-16 | Korean | ||
| 33027710 | 기업설명회(IR)개최 | 2025-10-28 | Korean | ||
| 33024158 | 투자판단관련주요경영사항(임상시험계획승인신청) (재조합 대상포진 백신(CVI-VZV-001)의 제 2상 임상시험 계획 승인 신청(IND)) | 2025-10-15 | Korean | ||
| 33024103 | 기업설명회(IR)개최 | 2025-10-15 | Korean | ||
| 33021369 | 주식등의대량보유상황보고서(일반) | 2025-09-30 | Korean | ||
| 33020365 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2025-09-25 | Korean | ||
| 7867448 | 주식등의대량보유상황보고서(일반) | 2025-09-01 | Korean | ||
| 7869943 | 임시주주총회결과 | 2025-08-25 | Korean | ||
| 7869942 | 대표이사변경 | 2025-08-25 | Korean | ||
| 7875800 | 반기보고서 (2025.06) | 2025-08-13 | Korean | ||
| 7877187 | 주주총회소집공고 | 2025-08-08 | Korean | ||
| 7884492 | 주주명부폐쇄기간또는기준일설정 | 2025-07-15 | Korean | ||
| 7884480 | 주주총회소집결의 (임시주주총회) | 2025-07-15 | Korean | ||
| 7886482 | 투자판단관련주요경영사항(임상시험결과) (재조합 대상포진 백신(CVI-VZV-001)의 제 1상 임상시험 결과보고서 수령) | 2025-07-08 | Korean | ||
| 7890102 | 기업설명회(IR)개최 | 2025-06-25 | Korean | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
CHA Vaccine Research Institute via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/17440/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=17440 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=17440 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=17440 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 17440}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for CHA Vaccine Research Institute (id: 17440)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.